Trials / Completed
CompletedNCT02310022
A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules
A Pharmacokinetic and Pharmacodynamic Study of Two Formulations of Omega-3 One Gram Capsules After Single and Multi-Dose Administrations Under Fed Conditions
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Matinas Biopharma, Inc · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Comparative bioavailability and pharmacodynamics effects of MAT9001 versus an active omega-3 medication comparator.
Detailed description
The primary objective is to determine the comparative bioavailability and pharmacodynamics effects of single and multiple doses of MAT9001 versus an active omega-3 medication comparator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Drug Omega 3 | 4 g (4 capsules) once a day, administered with food |
| DRUG | Drug Omega-3 Comparator | 4 g (4 capsules) once a day, administered with food |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-05-01
- Completion
- 2016-08-01
- First posted
- 2014-12-05
- Last updated
- 2020-10-12
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02310022. Inclusion in this directory is not an endorsement.